Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Realtime updates for Hemogenyx Pharmaceuticals [HEMO.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated26 Apr 2024 @ 11:25
25% discount on Stockinvest.us - Use code: Podcast

4.10% £ 1.650

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:25):

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases...

Stats
Today's Volume 1.89M
Average Volume 16.31M
Market Cap 21.27M
EPS £0 ( 2024-04-25 )
Next earnings date ( £0 ) 2024-06-28
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -1.650
ATR14 £0.0240 (1.45%)

Volume Correlation

Long: -0.19 (neutral)
Short: -0.75 (moderate negative)
Signal:(52.56) Neutral

Hemogenyx Pharmaceuticals Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hemogenyx Pharmaceuticals Correlation - Currency/Commodity

The country flag -0.25
( neutral )
The country flag -0.45
( neutral )
The country flag 0.00
( neutral )
The country flag -0.15
( neutral )
The country flag 0.00
( neutral )
The country flag 0.42
( neutral )

Hemogenyx Pharmaceuticals Financials

Annual 2023
Revenue: £0
Gross Profit: £-645 681 (0.00 %)
EPS: £-0.00600
FY 2023
Revenue: £0
Gross Profit: £-645 681 (0.00 %)
EPS: £-0.00600
FY 2022
Revenue: £0
Gross Profit: £-2.60M (0.00 %)
EPS: £-0.00440
FY 2021
Revenue: £0.00
Gross Profit: £-321 230 (0.00 %)
EPS: £-0.0123

Financial Reports:

No articles found.

Hemogenyx Pharmaceuticals

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators